Newsroom
Recent Announcements
PhotoPharmics brings renowned experts in Parkinson’s disease and other neurodegenerative diseases to advisory board
Clinical-stage medical device maker PhotoPharmics today announced a Clinical & Scientific Advisory board (CSAB) comprised of six leading experts in Parkinson’s disease (PD) and other neurodegenerative diseases. The board’s aim is to provide clinical and scientific advice and direction to support the PhotoPharmics mission to “Improve the lives of people who suffer from neurodegenerative diseases.”
Featured Article
“Breaking Through the FDA” (Biosphere, 2021)
Innovative medical devices and diagnostics can get to patients and providers sooner under the U.S. Food and Drug Administration’s (FDA) Breakthrough Device Program. The program provides a special regulatory Breakthrough Device Designation for medical products that have the potential to more effectively treat or diagnose serious or life-threatening conditions. See the full article on page 19 >
“There are only four kinds of people in this world: those who have been caregivers, those who are currently caregivers, those who will be caregivers and those who will need caregivers. Caregiving is universal.”
– Rosalynn Carter, former US First Lady
https://photopharmics.com/care-for-the-caregivers/
Caring for someone else—especially those with severe or advanced cases of Parkinson’s disease—can be exhausting, draining and even overwhelming. Thank you for all you do, caregivers!
3 days ago ·
4 days ago ·
6 days ago ·
Archived Content